Prevention of nitrogen mustard-induced apoptosis in normal and transformed lymphocytes by ebselen.
The alkylating agent, nitrogen mustard (HN2), is thought to cause apoptosis through production of free oxygen radicals. To explore the mechanism of HN2-induced apoptosis, we utilized ebselen, a selenoorganic compound with potent antioxidant activity. We examined whether ebselen would inhibit apoptosis in BALB/c mouse spleen lymphocytes and human MOLT-4 leukemia cells treated with HN2 (2.5 microM) in vitro. Non-toxic concentrations (<50 microM) of ebselen were found to prevent HN2-induced apoptosis of murine lymphocytes in a dose-dependent manner, as measured by cell viability, hypodiploid DNA formation, and phosphatidylserine externalization. However, ebselen was ineffective at preventing spontaneous apoptosis in these cells, pointing to the selectivity of its action. Furthermore, pretreatment with ebselen at 1-10 microM for 72 hr protected MOLT-4 cells from HN2-induced apoptosis and maintained cell viability and proliferation as monitored by the above-mentioned parameters. This was accompanied by the preservation of mitochondrial transmembrane potential and elevated glutathione levels and by a blockage of caspase-3 and -9 activation. In vivo, ebselen also had a marked protective effect against spleen weight loss associated with lymphocyte apoptosis in mice treated by HN2. Therefore, ebselen provides an efficient protection against HN2-induced cell death in normal and tumoral lymphocytes and might prove useful as an antidote against alkylating agents.
Holl
V
V
Laboratoire de Cancerologie Experimentale et de Radiobiologie (LCER), Institut de Recherche Contre les Cancers de l'Appareil Digestif (IRCAD), Hopitaux Universitaires, 67091, Strasbourg, France.
Coelho
D
D
Silbernagel
L
L
Keyser
J F
JF
Waltzinger
C
C
Dufour
P
P
Bischoff
P L
PL
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D017209:Apoptosis; D001393:Azoles / Q000494:pharmacology*; D002461:Cell Line, Transformed; D004347:Drug Interactions; D006801:Humans; D054833:Isoindoles; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects*; D008466:Mechlorethamine / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D016566:Organoselenium Compounds / Q000494:pharmacology*; D013154:Spleen / Q000166:cytology / Q000187:drug effects
D000975:Antioxidants; D001393:Azoles; D054833:Isoindoles; D016566:Organoselenium Compounds; C042986:ebselen; D008466:Mechlorethamine